Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions


Latest Cancer News

Cabometyx™ Improves Time to Cancer Progression as Initial Therapy in Kidney Cancer (December 5, 2016)

The agent Cabometyx™ (cabozantinib) improves anti-cancer responses and time to cancer progression compared to Sutent® (sunitinib) when used as initial therapy for advanced kidney cancer. These results... Continue Reading

Personalized Medicine: Access Is Power (December 1, 2016)

Personalized medicine has the potential to save women’s lives, but not if they can’t access it. By Stacey L. Worthy, Esq. One of the most exciting advances in health­care is the growing field of personal­ized... Continue Reading

Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions (December 1, 2016)

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring transfusions. These results were recently published... Continue Reading

Unmasking the Genetics of Early Heart Disease (November 30, 2016)

Catching familial hypercholesterolemia early can save lives  By Heather Stringer Katherine Wilemon was 15 when she discovered that she was living with extremely high cholesterol levels in her blood. At... Continue Reading

Opdivo® Improves Survival in Advanced Stomach Cancer (November 30, 2016)

The immune-stimulating agent Opdivo® (nivolumab) appears to significantly improve overall survival among patients with advanced stomach cancer for which no standard treatment options exist. Opdivo is... Continue Reading

Darzalex® Approved for Additional Indications in Multiple Myeloma (November 29, 2016)

The United States Food and Drug Administration (FDA) has approved Darzalex® (daratumumab) for the treatment of multiple myeloma among patients who have received at least one prior therapy. The new FDA... Continue Reading

Opdivo Approved for Advanced Head and Neck Cancer (November 28, 2016)

The United States Food and Drug Administration (FDA) has approved the immunotherapeutic agent, Opdivo® (nivolumab) for the treatment of advanced head and neck cancer. Specifically,  the indication is... Continue Reading

Gratitude, Community & Giving Thanks (November 23, 2016)

From all of us at CancerConnect, we hope you have a happy and healthy Thanksgiving. We are grateful to all of the members of our online community. We appreciate you sharing your stories and supporting... Continue Reading

It’s GERD Awareness Week–November 20th (November 20, 2016)

It’s that time of year again when there is a tendency to overindulge in a mélange of delicious foods. Although many people may only suffer discomfort from over eating, another group of people suffer... Continue Reading

Proud Purpose: Q&A with Joan Lunden (November 18, 2016)

Joan Lunden shares her personal perspective on how a cancer diagnosis has propelled her to become an advocate for cancer survivors and to recommit to health and wellness in her own life. As an award-winning... Continue Reading

Voices of Value: Lisa Goldman (November 18, 2016)

An all-too-common symptom of a delayed lung cancer diagnosis has spurred one patient to lend her voice to patient advocacy efforts. By Terry Wilcox In October 2013 Lisa Goldman went to the doctor because... Continue Reading

FDA Priority Review Granted for Midostaurin in Leukemia (November 17, 2016)

The United States Food and Drug Administration (FDA) has granted priority review to PKC412 (midostaurin) in the treatment of newly diagnosed acute myeloid leukemia (AML) with the FLT3 mutation, as well... Continue Reading

Useful Definitions for Chronic Myelogenous Leukemia (CML) (November 16, 2016)

Blood stem cell: An immature cell from which other types of blood cells develop. Bone marrow: The soft, sponge-like tissue in the center of most bones where blood cells are made. Chromosomes: Long strands... Continue Reading

Aromatase Inhibitor–Associated Joint Pain Tends to Resolve Upon Treatment Completion (November 15, 2016)

A class of drugs known as aromatase inhibitors (AI) commonly used in the management of estrogen receptor-positive (ER+) breast cancer are associated with troublesome joint pain. In fact, as many as half... Continue Reading

Chance of Surviving Childhood Cancer Has Improved–But Survivors’ Overall Health Has Not (November 14, 2016)

By Rachel Tompa Jasmine Jean is more than 30 years out from her original cancer treatments and her cancer is gone, but the experience is not behind her. “I don’t feel like I’ve ever been cured... Continue Reading

Keytruda Immunotherapy Improves Overall Survival in Bladder Cancer (November 10, 2016)

Bladder cancer will be diagnosed in approximately 77,000 people in the United States this year alone. The average age that patients are diagnosed with bladder cancer is 70 years, with 80% of these patients... Continue Reading

It’s in the Genes: Genetic Testing Tutorial (November 9, 2016)

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health... Continue Reading

Lynparza™ Clinical Trial Demonstrates Survival Benefit in Relapsed Ovarian Cancer (November 9, 2016)

AstraZeneca has announced positive results from the Phase III SOLO-2 trial designed to determine the efficacy of LynparzaTM (olaparib) oral therapy for the maintenance treatment of platinum-sensitive relapsed,... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions

Cancer Types

Headline News by Cancer Type

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS